Literature DB >> 6744584

Concentrations of Ag, Al, Au, Bi, Cd, Cu, Pb, Sb, and Se in cerebrospinal fluid of patients with cerebral neoplasms.

A El-Yazigi, I Al-Saleh, O Al-Mefty.   

Abstract

We measured the concentrations of nine trace elements in cerebrospinal fluid of 11 patients with malignant brain tumors, 11 with benign brain tumors, and 10 control patients, using flameless atomic absorption spectrophotometry. The mean and standard deviation for these concentrations (microgram/L) in the control group were 5.1 +/- 2.9 (silver), 326.6 +/- 171.2 (aluminum), 38.5 +/- 32.2 (gold), 36.6 +/- 23.7 (bismuth), 1.5 +/- 1.3 (cadmium), 39.8 +/- 24.7 (copper), 15.7 +/- 11.5 (lead), 20.9 +/- 3.8 (antimony), and 19.1 +/- 13.3 (selenium). Concentrations of silver and lead were markedly increased in patients with malignant cerebral neoplasms. The malignant-tumor/control patient concentration ratios were 2.31 for silver and 2.11 for lead. We observed no significant differences between the results for the benign tumor patients and the control group.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744584

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Selenium causes growth inhibition and apoptosis in human brain tumor cell lines.

Authors:  N Sundaram; A K Pahwa; M D Ard; N Lin; E Perkins; A P Bowles
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Manganese and selenium concentrations in cerebrospinal fluid of seriously ill children.

Authors:  Tomáš Franěk; Karel Kotaška; Richard Průša
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

3.  A case-control study of childhood brain tumors and fathers' hobbies: a Children's Oncology Group study.

Authors:  Andrea L Rosso; Mary E Hovinga; Lucy B Rorke-Adams; Logan G Spector; Greta R Bunin
Journal:  Cancer Causes Control       Date:  2008-06-17       Impact factor: 2.506

4.  Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma.

Authors:  Noah C Peeri; Jordan H Creed; Gabriella M Anic; Reid C Thompson; Jeffrey J Olson; Renato V LaRocca; Sajeel A Chowdhary; John D Brockman; Travis A Gerke; L Burton Nabors; Kathleen M Egan
Journal:  Cancer Epidemiol       Date:  2018-05-25       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.